S. Loukides (Athens, Greece), R. Louis (Liege, Belgium)
Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
M. Malerba, B. Ragnoli, A. Radaeli, C. Ricci, F. Lanzarotto, A. Lanzini (Brescia, Italy)
|   |
Are the flow independent NO parameters flow dependent?
M. Högman, P. Meriläinen (Gävle, Uppsala, Sweden)
| |
There is no need for complicated equations and mathematical models. Exhaled nitric oxide can be partitioned with two simple exhalations
P. Paredi, O. Usmani, K. Hurt, N. Pride, P. Barnes (London, United Kingdom)
| |
Can nasal-NO be used to differentiate between primary and secondary ciliary dyskinesia?
C. Krantz, A. Malinovischi, A. Hollsing, K. Alving (Uppsala, Sweden)
| |
Comparison of alveolar nitric oxide concentrations using two different methods for the assessment of small airways inflammation in asthma
D. Kobayashi, Y. Tochino, H. Kanazawa, Y. Ichimaru, K. Shigenori, K. Asai, K. Hirata (Osaka City, Japan)
| |
Exhaled breath temperature increases at COPD exacerbation and correlates with sputum neutrophilia
Z. Lázár, A. Bikov, G. Gálffy, M. Orosz, G. Losonczy, I. Hováth (Budapest, Hungary)
| |
Neutrophilic airways inflammation in lung cancer: The role of exhaled LTB-4 and IL-8
G. E. Carpagnano, D. Lacedonia, P. Bonfitto, S. Notarangelo, M. Grimaldi, G. Ciliberti, M. P. Foschino Barbaro (Foggia, Italy)
| |
HPV in exhaled breath condensate of lung cancer patients
G. E. Carpagnano, E. Costantino, D. Lacedonia, R. Decembrino, V. Turchiarelli, G. Rago, M. P. Foschino Barbaro (Foggia, Italy)
| |
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?
G. E. Carpagnano, A. Koutelou, A. Depalo, L. Bergantino, C. Ruggeri, D. Lacedonia, M. P. Foschino Barbaro (Foggia, Italy)
| |
Volatile organic compounds (VOCs) in COPD patients with exacerbation
V. Besa, K. Darwiche, H. Teschler, U. Sommerwerck, I. Kurth, T. Rabis, J. I. Baumbach, L. Freitag (Essen, Saarbruecken, Germany)
| |
Targeted eicosanoid lipidomics of induced sputum as compared to exhaled breath condensate in asthmatics
M. Sanak, L. Mastalerz, A. Gielicz, B. Sokolowska, N. Celejewska-Wójcik, A. Szczeklik (Kracow, Poland)
| |
Detection of pseudomonas aeruginosa (Pa) specific peaks by ion mobility spectrometry (IMS) in exhaled breath of bronchiectasis patients
T. Rabis, O. Anhenn, J. I. Baumbach, I. Kurth, G. Weinreich, H. Teschler, L. Freitag, K. Darwiche, U. Mellies, P. M. Rath, U. Sommerwerck (Essen, Saarbrücken, Germany)
| |
Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases
T. N. Anokhina, E. K. Anaev, A. A. Rodionov, A. I. Revelsky, I. A. Revelsky, V. B. Kudriavtsev, A. G. Chuchalin (Moscow, Russian Federation)
| |
Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
A. Ryabokon, V. Kurova, E. Anaev, A. Kononikhin, K. Fedorchenko, E. Nikolaev, S. Varfolomeev (Moscow, Russian Federation)
| |
NMR EBC metabonomic to assess the nutricecutic effect in COPD. A pilot study of oral administration of a curcumin based herbal preparation
G. de Laurentiis, G. Scapagnini, D. Paris, D. Melck, M. Maniscalco, A. Motta, S. Matteo, A. Bianco (Naples, Campobasso, Pozzuoli, Somma Vesuviana, Italy)
| |
Development of mass spectrometry approaches to quantifying lipid mediators in airway disease
D. Balgoma, S. L. Lundström, A. Eklund, J. Grunewald, C. E. Wheelock (Stockholm, Sweden)
| |
Follow up of lung transplant recipients using electronic nose
D. Kovacs, A. Bikov, J. Pako, Z. Kovats, Z. Sutto, V. Muller, G. Murakozy, G. Losonczy, I. Horvath (Budapest, Hungary)
| |
Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease
M. Bafadhel, M. McCormick, S. Saha, V. Mistry, S. McKenna, P. Dodson, A. Lloyd, P. Rugman, P. Newbold (Leicester, Loughborough, Sheffield, United Kingdom)
| |